| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ben Lin, Wenqiang He, Zhengyuan Chen, Ming Shen, Xuefei Shou, Long Chen, Zengyi Ma, Yongfei Wan. Self-reported symptoms in patients with acromegaly: a 6-month follow-up in a single neurosurgical center. Endocrine journal. 2022-10-05. PMID:36198614. |
acromegaly is characterized by hypersecretion of growth hormone (gh) and insulin-like growth factor 1 (igf-1), accompanied by a compromise in the perception of wellness. |
2022-10-05 |
2023-08-14 |
Not clear |
| Pamela U Fred. The acromegaly lipodystrophy. Frontiers in endocrinology. vol 13. 2022-09-30. PMID:36176462. |
growth hormone (gh) and insulin-like growth factor 1 (igf-1) are essential to normal growth, metabolism, and body composition, but in acromegaly, excesses of these hormones strikingly alter them. |
2022-09-30 |
2023-08-14 |
Not clear |
| Hakan Düğer, Hayri Bostan, Hilal Yıldırım Deryol, Narin Nasıroğlu İmga, Bekir Uçan, Murat Çalapkulu, Sema Hepşen, Pınar Akhanlı, Ümran Gül, Muhammed Erkam Sencar, Erman Çakal, Şeyda Özdemir, Muhammed Kızılgü. Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. vol 67. 2022-09-27. PMID:36166917. |
a paradoxical growth hormone (gh) response to oral glucose (og) in acromegaly can be observed. |
2022-09-27 |
2023-08-14 |
Not clear |
| Hakan Düğer, Hayri Bostan, Hilal Yıldırım Deryol, Narin Nasıroğlu İmga, Bekir Uçan, Murat Çalapkulu, Sema Hepşen, Pınar Akhanlı, Ümran Gül, Muhammed Erkam Sencar, Erman Çakal, Şeyda Özdemir, Muhammed Kızılgü. Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. vol 67. 2022-09-27. PMID:36166917. |
the role of the paradoxical gh response on how the patients with acromegaly respond to the treatment has been addressed in few studies. |
2022-09-27 |
2023-08-14 |
Not clear |
| Oboseh J Ogedegbe, Asfand Yar Cheema, Muhammad Ali Khan, Syeda Zeenat S Junaid, Jolomi K Erebo, Ewuradjoa Ayirebi-Acquah, Jennifer Okpara, Daramfon Bofah, Jennifer G Okon, Mishaal Munir, Gabriel Alugba, Aaron Ezekiel, Ohikhuare Okun, Tioluwani K Ojo, Eunice O Mejulu, Abdulmalik Jimo. A Comprehensive Review of Four Clinical Practice Guidelines of Acromegaly. Cureus. vol 14. issue 9. 2022-09-15. PMID:36105896. |
acromegaly is an endocrine disorder characterized by dysregulated hypersecretion of growth hormone (gh), leading to an overproduction of insulin-like growth factor 1 (igf-1). |
2022-09-15 |
2023-08-14 |
Not clear |
| Manisha Dixit, Leeann D Louis, Jelena Basta-Pljakic, Gozde Yildirim, Sher-Bahadur Poudel, Fancy Kumararaja, Edward O List, Silvana Ortiz Duran, John J Kopchick, Ryan R Ruff, Mitchell B Schaffler, Shoshana Yaka. Lifelong excess in GH elicits sexual dimorphic effects on skeletal morphology and bone mechanical properties. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2022-09-07. PMID:36069368. |
excess in growth hormone (gh) levels, seen in patients with acromegaly, is associated with increases in fractures. |
2022-09-07 |
2023-08-14 |
mouse |
| Xiang Li, Xiaolin Ni, Xiaofeng Chai, Linjie Wang, Yan Jiang, Hongli Jing, Li Huo, Huanwen Wu, Yong Yao, Jin Jin, Bin Feng, Yu Xia, Wei Yu, Yue Chi, Wei Liu, Qianqian Pang, Lijia Cui, Ruizhi Jiajue, Yiyi Gong, Ou Wang, Mei Li, Xiaoping Xing, Weibo Xi. Tumor-induced osteomalacia combined with acromegaly: A case report. Annals of the New York Academy of Sciences. 2022-09-03. PMID:36056464. |
both acromegaly and tumor-induced osteomalacia (tio) are rare diseases caused by an excess hormone secreted by neuroendocrine neoplasms, which are growth hormone (gh) and fibroblast growth factor 23 (fgf23), respectively. |
2022-09-03 |
2023-08-14 |
Not clear |
| Xiang Li, Xiaolin Ni, Xiaofeng Chai, Linjie Wang, Yan Jiang, Hongli Jing, Li Huo, Huanwen Wu, Yong Yao, Jin Jin, Bin Feng, Yu Xia, Wei Yu, Yue Chi, Wei Liu, Qianqian Pang, Lijia Cui, Ruizhi Jiajue, Yiyi Gong, Ou Wang, Mei Li, Xiaoping Xing, Weibo Xi. Tumor-induced osteomalacia combined with acromegaly: A case report. Annals of the New York Academy of Sciences. 2022-09-03. PMID:36056464. |
here, we report the first case with acromegaly combined with tio, the changing process of his phosphate concentration suggests an interesting concurrent effect of excess gh and fgf23 in this rare condition. |
2022-09-03 |
2023-08-14 |
Not clear |
| Masaaki Yamamoto, Yutaka Takahash. Genetic and Epigenetic Pathogenesis of Acromegaly. Cancers. vol 14. issue 16. 2022-08-26. PMID:36010855. |
acromegaly is caused by excessive secretion of gh and igf-i mostly from somatotroph tumors. |
2022-08-26 |
2023-08-14 |
Not clear |
| David P Bray, Sai Mannam, Rima S Rindler, Joseph W Quillin, Nelson M Oyesik. Surgery for acromegaly: Indications and goals. Frontiers in endocrinology. vol 13. 2022-08-22. PMID:35992136. |
acromegaly is a disease that occurs secondary to high levels of gh, most often from a hormone-secreting pituitary adenoma, with multisystem adverse effects. |
2022-08-22 |
2023-08-14 |
Not clear |
| N Bestepe, C Aydin, A A Tam, K Ercan, R Ersoy, B Caki. EMPTY SELLA IN A PATIENT WITH CLINICAL AND BIOCHEMICAL DIAGNOSIS OF ACROMEGALY. Acta endocrinologica (Bucharest, Romania : 2005). vol 18. issue 1. 2022-08-17. PMID:35975262. |
acromegaly is an acquired disorder related to excessive production of growth hormone (gh) and insulin-like growth factor-1 (igf-1). |
2022-08-17 |
2023-08-14 |
Not clear |
| Marcin Gierach, Roman Juni. Aberrations in carbohydrate metabolism in patients with diagnosed acromegaly - observational study. Endokrynologia Polska. 2022-08-16. PMID:35971939. |
acromegaly is characterized by excessive secretion of growth hormone (gh). |
2022-08-16 |
2023-08-14 |
Not clear |
| Zhe Zhao, Lian Duan, Daihui Gao, Yong Yao, Kan Deng, Bing Xing, Xinfeng Wang, Yan Tang, Huijuan Zhu, Xiaoguang Che. Efficacy and adverse events of octreotide long-acting release in acromegaly: a real-world retrospective study. Annals of translational medicine. vol 10. issue 13. 2022-08-12. PMID:35957714. |
octreotide long-acting release (lar) is a common drug used for acromegaly that aims to normalize serum growth hormone (gh) and insulin-like growth factor-1 (igf-1). |
2022-08-12 |
2023-08-14 |
Not clear |
| Sabrina Chiloiro, Antonio Bianchi, Antonella Giampietro, Alfredo Pontecorvi, Gérald Raverot, Laura De Marini. Second line treatment of acromegaly: Pasireotide or Pegvisomant? Best practice & research. Clinical endocrinology & metabolism. 2022-08-05. PMID:35931640. |
the treatment of acromegaly is mainly based on the surgical resection of the gh secreting pituitary tumor and, in cases with persistent disease, on the medical therapy with first generation somatostatin analogues (first gen-ssas). |
2022-08-05 |
2023-08-14 |
Not clear |
| Sabrina Chiloiro, Antonio Bianchi, Antonella Giampietro, Alfredo Pontecorvi, Gérald Raverot, Laura De Marini. Second line treatment of acromegaly: Pasireotide or Pegvisomant? Best practice & research. Clinical endocrinology & metabolism. 2022-08-05. PMID:35931640. |
data from national registries, meta-analysis and epidemiology studies showed that 24%-65% of acromegaly patients treated with first gen-ssa did not reach the control of disease, requiring second line therapies, as the second gen-ssas and the gh receptor antagonist. |
2022-08-05 |
2023-08-14 |
Not clear |
| João Roque, Pedro Marque. Acromegaly-related cutis verticis gyrata. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. vol 66. 2022-08-02. PMID:35917639. |
acromegaly is a disorder caused by hypersecretion of growth hormone (gh), resulting in excessive levels of insulin-like growth factor 1 (igf-1), and almost always due to a pituitary tumor. |
2022-08-02 |
2023-08-14 |
Not clear |
| Leandro Kasuki, Bernardo Maia, Mônica R Gadelh. Acromegaly and Colorectal Neoplasm: An Update. Frontiers in endocrinology. vol 13. 2022-07-07. PMID:35795151. |
acromegaly is a systemic disease caused by excessive inappropriate secretion of gh and igf-i levels, resulting in many systemic complications, including cardiovascular, respiratory, metabolic diseases, and a possible increased risk of some neoplasias. |
2022-07-07 |
2023-08-14 |
Not clear |
| M Stojanovic, M Popevic, S Pekic, M Doknic, D Miljic, M Medic-Stojanoska, D Topalov, J Stojanovic, A Milovanovic, M Petakov, S Damjanovic, V Popovi. Serum Insulin-Like Growth Factor-1 (IGF-1) Age-Specific Reference Values for Healthy Adult Population of Serbia. Acta endocrinologica (Bucharest, Romania : 2005). vol 17. issue 4. 2022-06-24. PMID:35747861. |
insulin-like growth factor-1 (igf-1) is main serum surrogate marker of growth hormone (gh) secretion, used in diagnostics and treatment of gh deficiency (ghd) and acromegaly. |
2022-06-24 |
2023-08-14 |
human |
| C Bona, N Prencipe, A M Berton, F Bioletto, M Parasiliti-Caprino, V Gasco, E Ghigo, S Grottol. Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy. Journal of endocrinological investigation. 2022-06-24. PMID:35748978. |
mean gh profile is more accurate than single fasting gh in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy. |
2022-06-24 |
2023-08-14 |
Not clear |
| C Bona, N Prencipe, A M Berton, F Bioletto, M Parasiliti-Caprino, V Gasco, E Ghigo, S Grottol. Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy. Journal of endocrinological investigation. 2022-06-24. PMID:35748978. |
this study aims to compare the accuracy of mean gh profile (ghp) < 2.5 ng/ml and single fasting gh (sgh) < 1 ng/ml in the evaluation of disease control in acromegaly patients during somatostatin receptor ligands (srls) therapy. |
2022-06-24 |
2023-08-14 |
Not clear |